Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saravanan Natarajan

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Data in Brief|April 28, 2022
Datasets comprising the quality validations of simulated protein-ligand complexes and SYBYL docking scores of bioactive natural compounds as inhibitors of <i>Mycobacterium tuberculosis</i> protein-targetsSravan Kumar Miryala, Soumya Basu, Aniket Naha, et al.
The Indian Journal of Medical Research|October 9, 2024
Malnutrition in tribal people living with tuberculosis in India: A systematic review & meta-analysisSilambu Chelvi Kannayan, Basilea Watson, Kannan Thiruvengadam, et al.
ACS Omega|January 20, 2025
Biomolecular Interaction of Carnosine and Anti-TB Drug: Preparation of Functional Biopeptide-Based Nanocomposites and Characterization through In Vitro and In Silico InvestigationsUsharani Nagarajan, Aniket Naha, Gayathri Ashok, et al.
Journal of Complementary & Integrative Medicine|May 8, 2021
Effects of co-administration of <i>Unani</i> pharmacopoeia formulations <i>Qurs Tabasheer Sartani</i> and <i>Arq Hara Bhara</i> with CAT-I antitubercular drugs in ratsNoor Zaheer Ahmed, Hemanth Kumar Agibothu Kupparam, Seema Akbar, et al.
Frontiers in Immunology|August 18, 2025
Previous COVID-19 infection significantly reduces elastase levels in newly diagnosed pulmonary tuberculosis patientsNancy Hilda Joseph, Alangudi Palaniappan Natarajan, Saravanan Natarajan, et al.
Open Forum Infectious Diseases|March 6, 2024
Safety and Efficacy of 25 mg/kg and 35 mg/kg vs 10 mg/kg Rifampicin in Pulmonary TB: A Phase IIb Randomized Controlled TrialBhavani Perumal Kannabiran, Natarajan Alangudi Palaniappan, Tamizhselvan Manoharan, et al.
The European Respiratory Journal|August 10, 2021
Host lipidome and tuberculosis treatment failureRupak Shivakoti, John W Newman, Luke Elizabeth Hanna, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Data in Brief|April 28, 2022
Datasets comprising the quality validations of simulated protein-ligand complexes and SYBYL docking scores of bioactive natural compounds as inhibitors of <i>Mycobacterium tuberculosis</i> protein-targetsSravan Kumar Miryala, Soumya Basu, Aniket Naha, et al.
The Indian Journal of Medical Research|October 9, 2024
Malnutrition in tribal people living with tuberculosis in India: A systematic review & meta-analysisSilambu Chelvi Kannayan, Basilea Watson, Kannan Thiruvengadam, et al.
ACS Omega|January 20, 2025
Biomolecular Interaction of Carnosine and Anti-TB Drug: Preparation of Functional Biopeptide-Based Nanocomposites and Characterization through In Vitro and In Silico InvestigationsUsharani Nagarajan, Aniket Naha, Gayathri Ashok, et al.
Journal of Complementary & Integrative Medicine|May 8, 2021
Effects of co-administration of <i>Unani</i> pharmacopoeia formulations <i>Qurs Tabasheer Sartani</i> and <i>Arq Hara Bhara</i> with CAT-I antitubercular drugs in ratsNoor Zaheer Ahmed, Hemanth Kumar Agibothu Kupparam, Seema Akbar, et al.
Frontiers in Immunology|August 18, 2025
Previous COVID-19 infection significantly reduces elastase levels in newly diagnosed pulmonary tuberculosis patientsNancy Hilda Joseph, Alangudi Palaniappan Natarajan, Saravanan Natarajan, et al.
Open Forum Infectious Diseases|March 6, 2024
Safety and Efficacy of 25 mg/kg and 35 mg/kg vs 10 mg/kg Rifampicin in Pulmonary TB: A Phase IIb Randomized Controlled TrialBhavani Perumal Kannabiran, Natarajan Alangudi Palaniappan, Tamizhselvan Manoharan, et al.
The European Respiratory Journal|August 10, 2021
Host lipidome and tuberculosis treatment failureRupak Shivakoti, John W Newman, Luke Elizabeth Hanna, et al.
Pageof 2